Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eur J Dermatol ; 33(6): 674-679, 2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-38465549

RESUMO

Actinic keratosis (AK) is the most common pre-malignant cutaneous lesion of the skin, often associated with field cancerization. Daylight photodynamic therapy (DL-PDT) is used as treatment, showing good histological results. Reflectance confocal microscopy (RCM) may be useful as a non-invasive, real-time approach to monitor treatment, however, there is a lack of data on the correlation between RCM and histopathological findings in AK patients treated with DL-PDT. To correlate histological and RCM findings and evaluate the efficacy of DL-PDT in patients with AK and field cancerization treated with DL-PDT. Patients with field cancerization and a minimum of six AK lesions on the face were included in the study. A single session combining methyl aminolevulinate followed by two-hour daylight exposure of the face was performed. RCM and biopsy were performed before and after three months of the intervention to compare efficacy between patients using the Wilcoxon test, and concordance of the findings based on the different methods was analysed using the Kappa test. Twenty-four patients completed the study. An improvement in photodamage and a decrease in the number of AK lesions (45.3% reduction) was observed. Regression in atypia and dysplasia was observed via histopathology and RCM, however, there was poor agreement between the methods. No changes were observed after treatment for inflammation, fibroplasia and acantholysis. Concordance between histological and RCM findings was poor, suggesting that RCM cannot replace the histopathological examination, however, it may be used as an adjuvant test for follow-up of patients. Despite this, DL-PDT proved to be an effective method for treating AK.


Assuntos
Ceratose Actínica , Fotoquimioterapia , Humanos , Ceratose Actínica/diagnóstico por imagem , Ceratose Actínica/tratamento farmacológico , Ceratose Actínica/etiologia , Fotoquimioterapia/métodos , Ácido Aminolevulínico/uso terapêutico , Inflamação , Protetores Solares/uso terapêutico , Microscopia Confocal/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Resultado do Tratamento
2.
Ann Dermatol Venereol ; 146 Suppl 2: IIS3-IIS9, 2019 May.
Artigo em Francês | MEDLINE | ID: mdl-31133227

RESUMO

Actinic keratosis is a premalignant skin lesion resulting from proliferation of atypical epidermal keratinocytes. Actinic keratoses are very frequent and their prevalence is increasing. Risk factors for actinic keratosis include intrinsic and environmental factors, particularly exposure to ultraviolet radiation and advanced age. The main factor is the exposition to ultraviolet radiation. Better sun protection decreases the risk of actinic keratosis and also the risk of progression to squamous cell carcinoma, even though not all actinic keratoses progress to invasive squamous cell carcinoma. A diagnosis of actinic keratosis should encourage patients to do an annual dermatological screening of skin cancers. Given the economic cost of actinic keratoses, a global approach of health authorities could be interesting for their management. © 2019 Elsevier Masson SAS. All rights reserved. Cet article fait partie du numéro supplément Kératoses actiniques : comprendre et traiter réalisé avec le soutien institutionnel de Galderma International.


Assuntos
Ceratose Actínica/epidemiologia , Fatores Etários , Carcinógenos/toxicidade , Humanos , Ceratose Actínica/economia , Ceratose Actínica/etiologia , Ceratose Actínica/prevenção & controle , Prevalência , Fatores de Risco , Fatores Sexuais , Neoplasias Cutâneas/etiologia , Luz Solar/efeitos adversos , Protetores Solares/administração & dosagem , Raios Ultravioleta/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA